51 results
A patient with multivalvular disease: which approach?
05 Apr 2022
An 81-year-old lady with past history of surgical aortic valve replacement followed by implantation of dual-chamber permanent pacemaker was admitted for recurrent episodes of right heart decompensations. The echocardiographic evaluation revealed massive TR and moderate primary MR due to a retracted posterior leaflet. What would be...

Author

Author

Right ventricular-pulmonary arterial coupling and afterload reserve in patients undergoing transcatheter tricuspid valve repair
10 Feb 2022
The authors hypothesized that disordered right ventricular to pulmonary artery (RV-PA) coupling may denote RV decompensation in patients undergoing transcatheter tricuspid valve repair (TTVR) that may correlate with poor clinical outcomes.

Reviewer

Reviewer

Cardiohepatic syndrome is associated with poor prognosis in patients undergoing tricuspid transcatheter edge-to-edge valve repair
27 Jan 2022
As the prognostic role of cardiohepatic syndrome (CHS) has not yet been evaluated, Stolz et al. in the present study assessed its impact on T-TEER outcomes.

Reviewer

Reviewer

Top 10 most cited 2021 articles in the Transcatheter Tricuspid field
11 Jan 2022
A. Sticchi and J. Curio provide you with a summary of the studies that highlighted 2021 in the field of transcatheter tricuspid intervention: TRILUMINATE, CLASP TR EFS, EVOQUE TTVR, TRI-REPAIR, and more.

The role of imaging in transcatheter treatment for tricuspid valve disease
Alex Sticchi, interventional cardiologist, interviews Rebecca Hahn, Interventional Echocardiographer, about a recent State of the Art article about transcatheter treatment for tricuspid valve disease published in EuroIntervention.
They discuss the importance of starting with the classification of anatomy and that of secondary TR and identifying how clinical...

State-of-the-art: Transcatheter treatment for tricuspid valve disease
19 Nov 2021
The development and successful results of transcatheter aortic valve implantation, followed by transcatheter therapies for mitral valve disease have opened a myriad of opportunities for transcatheter treatment of TR. Read this State-of-the-Art paper published in EuroIntervention by the PCR Tricuspid Focus Group.

TRISCEND: six-month outcomes of transfemoral tricuspid valve replacement in patients with TR - a written review
09 Nov 2021
The 6-month follow-up of the TRISCEND study was presented during the TCT Congress 2021 by principal investigator Susheel Kodali. Alessandro Sticchi & Jonathan Curio offer a review of this trial.

Author

Author

TRISCEND Six-Month Outcomes of Transfemoral Tricuspid Valve Replacement in Patients With Tricuspid Regurgitation
07 Nov 2021
Alessandro Sticchi interviews Susheel Kodali, PI of the TRISCEND trial, presented at TCT 2021. They discuss the main results of the study, its impact on the field of Tricuspid and the upcoming TRISCEND II study.

Author

Author

#2 - Tricuspid valve interventions: patient and device selection
19 Oct 2021
Discover the replay of this PCR Webinar on tricuspid valve disease with F. Maisano, R. von Bardeleben, J. L. Zamorano, J. Cavalcante, P. Lurz and G. Nickenig. Learn about transcatheter tricuspid valve procedures, and more!

#1 - Natural history and prognosis of tricuspid valve disease
23 Sep 2021
PCR Webinar with M. Metra, F. Praz, M. Sitges, E. Donal, R. Hahn, D. Muraru and Y. Topilsky

#3 - Tricuspid valve lifetime management
04 Aug 2021
Watch the replay of this PCR Webinar on tricuspid valve management with L. Sondergaard, H. Treede, N. Wunderlich, L. Conradi, J. Hausleiter and A. Latib

- ← previous
- 1
- 2
- 3
- next →